about
Optical imaging of bacterial infection in living mice using deep-red fluorescent squaraine rotaxane probesBacteria tracking by in vivo magnetic resonance imaging.Nuclear imaging: a powerful novel approach for tuberculosis.Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeuticPET imaging of bacterial infections with fluorine-18-labeled maltohexaose.Molecular imaging of bacterial infections in vivo: the discrimination of infection from inflammation.A Systematic Approach for Developing Bacteria-Specific Imaging Tracers.Expanding role of 18F-fluoro-D-deoxyglucose PET and PET/CT in spinal infections.The molecular imaging approach to image infections and inflammation by nuclear medicine techniques.Progress in diagnosis and treatment of cervical postoperative infection.Prosthetic joint infections: radionuclide state-of-the-art imaging.Fungal central nervous system infections: prevalence and diagnosis.Functional Imaging in Diagnostic of Orthopedic Implant-Associated Infections.Technetium-99m based small molecule radiopharmaceuticals and radiotracers targeting inflammation and infection.Radiolabeling and Preliminary Evaluation of Ga-68 Labeled NODAGA-Ubiquicidin Fragments for Prospective Infection Imaging.(68) Ga-labeled Ciprofloxacin Conjugates as Radiotracers for Targeting Bacterial Infection.Pathogen-Specific Bacterial Imaging in Nuclear Medicine.MRI detection of bacterial brain abscesses and monitoring of antibiotic treatment using bacCEST.A Comparative 68Ga-Citrate and 68Ga-Chloride PET/CT Imaging of Staphylococcus aureus Osteomyelitis in the Rat Tibia.Positron Emission Tomography Imaging with 2-[F]F- p-Aminobenzoic Acid Detects Staphylococcus aureus Infections and Monitors Drug Response
P2860
Q30495780-830E7110-F8A2-4420-8EC6-9727DD7CEDD7Q30540773-AD6B32D9-1CBF-485D-AF09-20B174C7EC2FQ34315731-738BC359-933C-4BAB-BB09-B2AE4C32607FQ34650340-4AC2F44C-E3B0-4E2B-9913-9E8071622AE6Q35602940-004875CA-4ACB-4036-9B48-4A80B2243C2CQ36683890-14B36F40-5226-40E0-BB30-49867A2CD485Q37554219-738CFD62-1B03-41C5-89D5-B2421E67821FQ37669252-06ACF8A5-8036-428F-8D1E-48AEED2C7922Q37916333-ACE9C348-BC6E-4015-8678-15CF0EC64F63Q37947167-92ED105A-9DD7-44E6-9FE7-26401CD96106Q37987812-FBB0CD3A-DE17-4545-9C87-1FBE6D65B3DAQ38176043-3952A093-7C75-403F-878F-C1EC494F74EDQ38716002-6F8B39A3-A113-4513-8FB6-9CBFB0ED5376Q40084585-BE19828A-2493-442D-AE13-A606A510C0BAQ40616136-AB3F802E-FAC3-402B-90D2-7FF27C18FDC7Q40878782-044D24FA-05E2-4C54-8669-FF6835F4F7CDQ49920607-D4377EFA-362C-4DDE-A7ED-A04FB2FFB83BQ52632215-92D2FB67-A066-4FB8-B131-BE5E12571817Q53404798-30B6A42C-24B3-419F-A22C-918B9766E223Q58767238-D746A1AE-7CA1-45D2-9573-8D37EE4856D1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Future diagnostic agents.
@en
Future diagnostic agents.
@nl
type
label
Future diagnostic agents.
@en
Future diagnostic agents.
@nl
prefLabel
Future diagnostic agents.
@en
Future diagnostic agents.
@nl
P1476
Future diagnostic agents
@en
P2093
Filip Gemmel
Nicolas Dumarey
P356
10.1053/J.SEMNUCLMED.2008.08.005
P577
2009-01-01T00:00:00Z